Solifenacin succinate Overview Categories 29 Drugs used in renal, bladder, and prostatic disorders Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Almitrine Manufacturers of Almitrine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Almitrine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 to 10 mg7.5 (7.5)24 hourlyPOIt can be administered with or without food. In patients with sever renal impairment (CLcr < 30 ml/min) and moderate hepatic impairment; greater than 5 mg/day dose is not recommended. It should not be taken in case of sever hepatic impairment. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Almitrine is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Almitrine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Almitrine Back to top Manufacturers of Solifenacin succinate in Pakistan Efroze Getz Helix Highnoon Ray Back to top Previous Drug Generic - Next Drug Generic
Solifenacin succinate Overview Categories 29 Drugs used in renal, bladder, and prostatic disorders Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Almitrine Manufacturers of Almitrine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Almitrine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 to 10 mg7.5 (7.5)24 hourlyPOIt can be administered with or without food. In patients with sever renal impairment (CLcr < 30 ml/min) and moderate hepatic impairment; greater than 5 mg/day dose is not recommended. It should not be taken in case of sever hepatic impairment. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Almitrine is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Almitrine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Almitrine Back to top Manufacturers of Solifenacin succinate in Pakistan Efroze Getz Helix Highnoon Ray Back to top Previous Drug Generic - Next Drug Generic